Peñaranda et al., 2019 - Google Patents
Profiling the Atlantic salmon IgM+ B cell surface proteome: novel information on teleost fish B cell protein repertoire and identification of potential B cell markersPeñaranda et al., 2019
View HTML- Document ID
- 10089726728750135348
- Author
- Peñaranda M
- Jensen I
- Tollersrud L
- Bruun J
- Jørgensen J
- Publication year
- Publication venue
- Frontiers in immunology
External Links
Snippet
Fish immunology research is at a pivotal point with the increasing availability of functional immunoassays and major advances in omics approaches. However, studies on fish B cells and their distinct subsets remain a challenge due to the limited availability of differentially …
- 210000004027 cells 0 title abstract description 196
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Peñaranda et al. | Profiling the Atlantic salmon IgM+ B cell surface proteome: novel information on teleost fish B cell protein repertoire and identification of potential B cell markers | |
Riquelme et al. | TIGIT+ iTregs elicited by human regulatory macrophages control T cell immunity | |
Coquery et al. | BAFF regulates follicular helper T cells and affects their accumulation and interferon‐γ production in autoimmunity | |
Chevrier et al. | IL4 and IL21 cooperate to induce the high Bcl6 protein level required for germinal center formation | |
EP2635299B1 (en) | Methods for treating hair loss disorders | |
Lu et al. | SLAM receptors foster iNKT cell development by reducing TCR signal strength after positive selection | |
JP2020195393A (en) | Engineered cells for adoptive cell therapy | |
JP2021516996A (en) | Biologically related orthogonal cytokine / receptor pair | |
CN109790213B (en) | Methods for identifying LILRB blocking antibodies | |
US20210077580A1 (en) | Multiple-variable il-2 dose regimen for treating immune disorders | |
JP2021502113A (en) | Methods, compositions, and components for CRISPR-CAS9 editing of TGFBR2 in T cells for immunotherapy | |
Chang et al. | Dichotomous expression of TNF superfamily ligands on antigen-presenting cells controls post-priming anti-viral CD4+ T cell immunity | |
Trefny et al. | Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy | |
US20220225597A1 (en) | Mouse model for assessing toxicities associated with immunotherapies | |
Mair et al. | Porcine CD3+ NKp46+ lymphocytes have NK-cell characteristics and are present in increased frequencies in the lungs of influenza-infected animals | |
Taylor et al. | A leukocyte immune-type receptor subset is a marker of antiviral cytotoxic cells in channel catfish, Ictalurus punctatus | |
Colden et al. | Insights into the emergence of paroxysmal nocturnal hemoglobinuria | |
Huang et al. | Neutrophils regulate humoral autoimmunity by restricting interferon-γ production via the generation of reactive oxygen species | |
JP2023182711A (en) | Methods, compositions, and components for crispr-cas9 editing of cblb in t cells for immunotherapy | |
Belosevic et al. | Development of goldfish macrophages in vitro | |
AU2018336522A1 (en) | A gRNA targeting HPK1 and a method for editing HPK1 gene | |
Nakayama et al. | Lymphotoxin-beta receptor blockade induces inflammation and fibrosis in tolerized cardiac allografts | |
Molina et al. | Regulatory dendritic cells induced by bendamustine are associated with enhanced Flt3 expression and alloreactive T-cell death | |
D'Alincourt Salazar et al. | Evaluation of innate and adaptive immunity contributing to the antitumor effects of PD1 blockade in an orthotopic murine model of pancreatic cancer | |
Wu et al. | Development and function of chicken XCR1+ conventional dendritic cells |